Efavirenz a nonnucleoside reverse transcriptase inhibitor of first-generation: Approaches based on its medicinal chemistry
Acquired immunodeficiency syndrome (AIDS) is a disease caused by human
immunodeficiency virus (HIV) that affects individuals on all continents. In 1987, the …
immunodeficiency virus (HIV) that affects individuals on all continents. In 1987, the …
Development of anti-viral agents using molecular modeling and virtual screening techniques
J Kirchmair, S Distinto, K Roman Liedl… - … Current Drug Targets …, 2011 - ingentaconnect.com
Computational chemistry has always played a key role in anti-viral drug development. The
challenges and the quickly rising public interest when a virus is becoming a threat has …
challenges and the quickly rising public interest when a virus is becoming a threat has …
CoMFA and CoMSIA studies on thiazolidin-4-one as anti-HIV-1 agents
V Murugesan, YS Prabhakar, SB Katti - Journal of Molecular Graphics and …, 2009 - Elsevier
Comparative molecular field analysis (CoMFA) and comparative molecular similarity indices
analysis (CoMSIA) were performed on thiazolidin-4-one class of compounds as HIV-1 …
analysis (CoMSIA) were performed on thiazolidin-4-one class of compounds as HIV-1 …
Pyridones as NNRTIs against HIV-1 mutants: 3D-QSAR and protein informatics
CoMFA and CoMSIA based 3D-QSAR of HIV-1 RT wild and mutant (K103, Y181C, and
Y188L) inhibitory activities of 4-benzyl/benzoyl pyridin-2-ones followed by protein …
Y188L) inhibitory activities of 4-benzyl/benzoyl pyridin-2-ones followed by protein …
Molecular and crystal structure of efavirenz, a potent and specific inhibitor of HIV-1 reverse transcriptase, and its monohydrate
K Ravikumar, B Sridhar - Molecular Crystals and Liquid Crystals, 2009 - Taylor & Francis
The crystal structures of efavirenz, systematic name:(S)-6-chloro-4-(cyclopropylethynyl)-1, 4-
dihydro-4-(trifluoromethyl)-2H-3, 1-benzoxazin-2-one, C14H9ClF3NO2,(I), a potent and …
dihydro-4-(trifluoromethyl)-2H-3, 1-benzoxazin-2-one, C14H9ClF3NO2,(I), a potent and …
HIV-1 non-nucleoside reverse transcriptase inhibitors: SAR and lead optimization using CoMFA and CoMSIA studies (1995-2016)
M Vanangamudi, V Poongavanam… - Current Medicinal …, 2017 - ingentaconnect.com
Background: Design of inhibitors for HIV-1 reverse transcriptase inhibition (HIV-1 RT) is one
of the successful chemotherapies for the treatment of HIV infection. Among the inhibitors …
of the successful chemotherapies for the treatment of HIV infection. Among the inhibitors …
Quantum chemical and experimental studies on the structure and vibrational spectra of efavirenz
Efavirenz,(S)-6-chloro-4 (cyclopropylethynyl)-1, 4-dihydro-4-(trifluoromethyl)-2H-3, 1-
benzoxazin-2-one, is a anti HIV agent belonging to the class of the non-nucleoside inhibitors …
benzoxazin-2-one, is a anti HIV agent belonging to the class of the non-nucleoside inhibitors …
Multiple drugs and multiple targets: An analysis of the electrostatic determinants of binding between non‐nucleoside HIV‐1 reverse transcriptase inhibitors and …
MS Minkara, PH Davis… - … : Structure, Function, and …, 2012 - Wiley Online Library
We present a systematic, computational analysis of the electrostatic component of binding of
three HIV‐1 RT inhibitors—nevirapine (NVP), efavirenz (EFV), and the recently approved …
three HIV‐1 RT inhibitors—nevirapine (NVP), efavirenz (EFV), and the recently approved …
Outlook on Thailand's genomics and computational biology research and development
W Tongsima, S Tongsima… - PLoS Computational …, 2008 - journals.plos.org
With a wealth of biodiversity, a long tradition of agriculture-based industries, and an
established medical and biotechnological research and development community, Thailand …
established medical and biotechnological research and development community, Thailand …
Classification of anti-HIV compounds using counterpropagation artificial neural networks and decision trees
M Jalali-Heravi, A Mani-Varnosfaderani… - SAR and QSAR in …, 2011 - Taylor & Francis
The main aim of the present work was to collect and categorize anti-HIV molecules in order
to identify general structure–activity relationships. In this respect, a total of 5580 drugs and …
to identify general structure–activity relationships. In this respect, a total of 5580 drugs and …